The First European Demostraton Center of BLT's In-vivo Imaging System is established !

On October 7, 2024, the Karolinska Institutet announced that the Nobel Prize in Physiology or Medicine for 2024 will be awarded to scientists Victor Ambros and Gary Ruvkun for their discovery of microRNAs and their role in post-transcriptional gene regulation. On October 19, 2024, Guangzhou Biolight Biotechnology  Co., Ltd (hereinafter referred to as "BLT")  and Clinical Research Center, Karolinska Institutet of Medicine  (hereinafter referred to as "Karolinska Institutet") officially announce  the establishment of the collaborative In-vivo Imaging Center at Karolinska Institutet of Medicine. 

This momentous occasion is an important step in BLT's internationalization and marks a new step in biomedical research between BLT and Karolinska Institutet. The newly established in vivo imaging center is equipped with BLT's state-of-the-art AniView Phoenix full-spectrum animal in vivo imaging system, which will provide researchers with cutting-edge technical support to further advance the exploration of disease mechanisms and the development of new therapies.

Currently, the Karolinska Institutet Clinical Research Center-Guangzhou BLT In-vivo Imaging Center is the first overseas demonstration center established by BLT. In the future, BLT will also establish several demonstration centers around the world, including North America, to build a comprehensive global service system to better serve our user community.

As one of the world's leading medical research institutions, Karolinska Institutet is not only world-renowned for its scientific research and education, but also for being responsible for selecting the Nobel Prize in Physiology or Medicine each year. This collaboration with BLT opens a new chapter in the field of biomedical research and highlights the shared vision of both parties in advancing scientific discovery and improving human health.

In order to ensure the smooth installation and quick application of the equipment, a team of professional engineers from BLT traveled to Karolinska Institutet of Medical Sciences to complete the installation and commissioning of the equipment and provided detailed operation training for the researchers.

As an innovative device integrating cutting-edge technology, the AniView Phoenix Full Spectrum Animal In-vivo Imaging System will play a key role in the study of disease mechanisms and the development of new therapies. Researchers at the Clinical Research Center of Karolinska Institutet of Medicine highly praised the system, saying it will significantly accelerate their research process and improve efficiency and quality. Through this collaboration, we expect more major breakthroughs in the life sciences to be quickly translated into practical applications for the benefit of all mankind. This is exactly the direction in which BLT and Karolinska Institutet are working together. 

Device Information: 

Aniview Phoenix is a full-spectrum in-vivo imaing system. It can realize real-time multi-modal imaging of living animals under non-invasive conditions, and supports fluorescence and bioluminescence imaging in the full spectral range from visible light to near infrared II. Equipped with high resolution, versatility, automated control, intuitive and easy-to-use operating software and powerful data management and analysis tools, it is suitable for a wide range of biological research scenarios, simplifies the experimental process and significantly improves the efficiency of scientific research.